Bleakley Financial Group’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.74M	Sell	43,694 -45,999	-51%	-$3.68M	0.04%	327
2025 Q4	$8.55M	Buy	89,693 +2,301	+3%	+$226K	0.15%	112
2025 Q3	$8.53M	Buy	87,392 +7,232	+9%	+$749K	0.2%	89
2025 Q2	$8.61M	Buy	80,160 +20,881	+35%	+$2.11M	0.22%	86
2025 Q1	$5.98M	Buy	59,279 +6,901	+13%	+$695K	0.19%	104
2024 Q4	$4.68M	Buy	52,378 +12,788	+32%	+$1.13M	0.14%	125
2024 Q3	$3.32M	Sell	39,590 -245,894	-86%	-$19.4M	0.1%	173
2024 Q2	$22M	Sell	285,484 -2,490	-0.9%	-$182K	0.63%	25
2024 Q1	$19.7M	Buy	287,974 +16,592	+6%	+$1.07M	0.57%	27
2023 Q4	$15.7M	Buy	271,382 +3,010	+1%	+$161K	0.5%	38
2023 Q3	$14.2M	Buy	268,372 +6,562	+3%	+$344K	0.5%	37
2023 Q2	$14.2M	Buy	261,810 +4,449	+2%	+$232K	0.44%	42
2023 Q1	$12.9M	Buy	257,361 +7,461	+3%	+$352K	0.43%	43
2022 Q4	$11.6M	Buy	+249,900	New	+$10.8M	0.41%	47